Current Drug Targets

Dr. Claudio Campa has been affiliated with the University of Ferrara, Italy, where he received his PhD in Pharmacology and Molecular Oncology, in 2008. He has authored many scientific papers in various journals including peer-reviewed journals that are indexed in PubMed, journals cited in current contents or index medicus and book chapters. Being an editorial board member, he is actively involved in Case Reports of Ophthalmological Medicine (Hindawi Publishing Corporation) (since 2014) and World Journal of Ophthalmology (Baishideng Publishing) (since 2012). As a co-investigator and sub-investigator, he has served many years in research specifically in clinical investigations.

Dr. Andrea Del Fattore is currently serving as a head of the Bone Physiopathology Group, Multifactorial Disease and Complex Phenotype Research Area, in Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy. He received a PhD degree in Biotechnology from the Department of Experimental Medicine, University of L’Aquila, Italy, in 2009. Later, in 2017 he completed his post-graduation with Specialization in Clinical Pathology and Clinical Biochemistry Tor Vergata, University of Rome, Italy. He has been actively involved in the editorial board of several international journals, various international committees and acted as reviewer in many highly reputed journals. Dr. Fattore has published over 40 articles, 3 book chapters and more than 30 abstracts till date.

Dr. Xu is the Associate Professor at Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology. He specializes in researches on pharmacology, cardiovascular and metabolic diseases, and discovery and evaluation of effective components from Chinese Medicines. His research interests mainly include: (1) study of Chinese Medicines on diabetes; (2) effects and mechanism of natural products on cardio-cerebrovascular disease; (3) development and application of alive cell immobilized chromatography on the R&D of Chinese Medicines. He has been awarded prizes including the Second Prize of Science and Technology Invention Award Category of the 2016 Macau Science and Technology Award (the second awardee), and Third Prize of 2011 Science and Technology Award of Jiangsu Province (the seventh awardee), etc. for academic performance.

Dr. Jeremy J. Johnson received his Ph.D. degree in Comparative and Biomedical Sciences in 2010 and Pharm.D. degree in 2007 from the University of Wisconsin School of Pharmacy. Dr. Johnson is an Associate Professor at the University of Illinois, Chicago. Currently, he is actively engaged in UI-Centre (University of Illinois Collaborative Engagement in Novel Therapeutics Research Enterprise) as a Pre-Clinical Core Leader and Associate Professor. He has an H-index of 18 with nearly 45 publications including 26 peer reviewed, 18 abstracts and 1 book chapter, respectively.

Dr. Shahper Nazeer Khan did M.Sc. in Biotechnology from Awadhesh Pratap Singh University, Rewa, Madhya Pradesh, India, in 2003. He further obtained M.Phil. and Ph.D. degrees in Biotechnology from Interdisciplinary Biotechnology Unit, Aligarh Muslim University, India, in 2006 and 2009. Nowadays, he is serving as an Assistant Professor at Interdisciplinary Nanotechnology Centre and Int. Biotechnology Unit, AMU, India. Dr. Khan has won several awards and received many honors as a consequence of his research and contributions in science, both nationally and internationally. He has published more than 40 papers. In addition to this, he’s also involved as an editorial board member in 6 scientific journals.

Dr. Bijo Mathew is an Associate Professor of Pharmaceutical Chemistry at Amrita School of Pharmacy, Kochi, India. Dr. Bijo Mathew obtained his M.Pharm in Pharmaceutical Chemistry from The Tamilnadu Dr. M.G.R. Medical University, Tamilnadu, India in 2008 and Ph.D. in Pharmaceutical Sciences from Jawaharlal Nehru Technological University, Hyderabad, India, in 2016. Mathew's primary areas of focus are drug discovery of neurodegenerative disorders, cancer, and molecular modelling. Besides, he is also interested in designing enzyme inhibitors, especially monoamine oxidase and acetylcholinesterase inhibitors. He has published 142 papers, (h-index = 29, the number of citations: 2222 in Google scholar; h-index = 27, the number of citations: 1887 in Scopus, as of March 2021). He has 13 years of teaching and research experience, as well as he has authored 1 book, and edited 1 book, and 5 book chapters. Moreover, he has been invited as a speaker in 25 national and international events. Dr. B. Mathew is serving as a chief executive guest editor for many journals and Section Editor of the journal of Coronaviruses by Bentham Science. He has received one patent from the Korean Intellectual Property of Office on protective or therapeutic compositions of neurological disorders containing Furano chalcones as effective agents.

Dr Dilipkumar Pal received his B.Pharm, M Pharm, and PhD from Jadavpur University, Kolkata, India. He also obtained his Post Doctorate from “The University of Sydney”, Australia. Currently, he is an Associate Professor at the Institute of Pharmaceutical Sciences, Guru Ghasidas Viswavidyalaya (A Central University), India. He has won several awards due to his contributions in Science both nationally and internationally. He has published more than 100 research papers, 28 book chapters, 12 review articles, and 112 abstract proceedings in both national and international journals. Besides, he is a Reviewer of 27 scientific journals and an Editorial Board Member of 29 scientific journals respectively.

Luciana Scotti received her Ph.D. in Cosmetology and Molecular Modeling at the University of São Paulo, Brazil. She made 3 years of Post-Doctorate in Pharmaceuticals at the Laboratory of Planning and Synthesis of Potentially Active Chemotherapies in Tropical Endemics, Faculty of Pharmaceutical Sciences, USP. She has experience in Pharmacology Biochemistry and Molecular acting mainly in the following areas: natural products, Molecular Modeling, QSAR, and Chemometrics. She is the professor of the Post-Graduate Program of Bioactive Natural and Synthetic Products of the Federal University of Paraíba, Brazil.

Dr. Chandrabose Selvaraj is currently working as a research specialist at CEITEC – Central European Institute of Technology, Masaryk University, Brno, Czech Republic. He has completed his doctoral studies in Bioinformatics (2014) from Alagappa University, India. He worked as a post-doctoral researcher in multiple international esteemed institutes that include National Center for Toxicology Research, Food and Drug Administration (USA); Central European Institute of Technology (Czech Republic), Konkuk University (Republic of Korea) and Indian Institute of Technology- Mandi (India). He has been awarded with European OP VVV MSCA-IF call 2017, ORISE IF- 2015, BIRD Special Mention award - 2012, and Young Researcher award-2010. His expertise includes computer simulation of biomolecules, and recognition mechanisms for protein-protein, protein-nucleic acid, protein- carbohydrate, and protein-ligand interactions. As an author / co-author he has published over 50 manuscripts in peer reviewed journals, 6 book chapters. Overall the applicant has 674 citations and holds the h-index of 17. All the research works published in the journals that come under the Top 25% of journals ranked by Clarivate analytics.

Dr. Petros Sountoulidis has been affiliated with Aristotle University of Thessaloniki, Greece, from where he passed MBBS, in 1996. Currently, he is serving as an Assistant Professor of Urology, Department of Urology at the same university. He has been involved with great endeavor in FEBU (Fellow of the European Board of Urology) and was awarded in 2005. He has served 8 years as a Consultant Urological Surgeon, Urology Department, General Hospital of Veria, Greek National Health System. As an editorial board member, he was involved in various esteemed journals and he has served as a reviewer for different Journals and provided 112 reviews in total. So far, he has published 5 book chapters.

Dr. Andrés Trostchansky obtained his Ph.D. in Chemistry at the Universidad de la Republica, Uruguay in 2007. Since 2010 he has been an Associate Professor at the Department of Biochemistry at the Facultad de Medicina. He is Co-PI of the Laboratory of Oxidative Lipid Biochemistry and a member of the Centro de Investigaciones Biomédicas (CEINBIO). Dr. Trostchanksy’s main research is focused in lipid metabolism, lipidomics studies in health and disease, nitro-fatty acids and their biological roles in arachidonic acid metabolism (COX and LOX) and reactive oxygen species (NOX and PDI). He served as a mentor for Ph.D. students in Uruguay and Brazil. He has authored/co-authored more than 50 manuscripts and book chapters on a variety of subject matters. He is among the editorial board of Frontiers of Experimental Pharmacology and Drug Discovery, Current Drug Target, and also a Section Editor of Current Medicinal Chemistry.

Dr. Joana Valente is a post-doctoral researcher at the Centre for Rapid and Sustainable Product Development. She obtained her PhD in Biochemistry in 2018 from the University of Beira Interior, with the thesis entitled: “Affinity purification and delivery of a p53-encoding plasmid DNA for gene-mediated cancer therapy”. Her scientific path began in 2009 when she started to work at the Centre for Rapid and Sustainable Product Development after concluding her degree in Biomechanics. During this period, she worked with 3D printing and surface modification to increase the suitability of the scaffolds for cell adhesion. In 2011, she obtained her Master’s degree in Engineering Design and Product Development, from Polytechnic Institute of Leiria with the thesis entitled: “Surface modification of alginate scaffolds”. Besides, in 2011, she pursued her career in the Health Sciences Research Centre in the bone regeneration field and, in 2013, she began to work with gene therapy and affinity chromatography. She is the author of several scientific papers and her main research interests include: Tissue Engineering, Biofabrication, Additive Manufacturing, Drug delivery systems development, Biomaterials, Gene therapy and Chromatography.

Dr. Hilal Zaid is presently serving as a Head of Al-Qasemi Educational Research Center, Al-Qasemi Academic College, Baka, Israel. He completed his M.Sc. from the department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israelin 1996. He further obtained PhD from the same university in 2005. He is also a Management Committee member of European Cooperation in Science and Technology (COST) Action N°CA15129, titled "Diagnosis, Monitoring and Prevention of Exposure-Related Noncommunicable Diseases (DiMoPEx)".